Health ❯ Public Health

Drug Policy

Fentanyl Crisis Harm Reduction Opioid Crisis Substance Abuse Health Risks Decriminalization Drug Deaths Naloxone Distribution Marijuana Cannabis Legislation Overdose Prevention Addiction Treatment Medical Marijuana Impact of Convictions Medical Treatment Regional Drug Plan Synthetic Drugs Access to Medication Pill Testing Youth Programs Medicare Drug Consumption Facilities Addiction Issues Cannabis Effects Cannabis Marijuana Restrictions Marijuana Rescheduling Cannabis Use Recreational Drug Use Drug Decriminalization Cannabis Legalization Health Minister Germany Illicit Drugs Decriminalization Impact Criminal Penalties Marijuana Legalization Rehabilitation Opioid Use Xylazine Regulation Survey Methodology Safer Supply Substance Regulation FDA Actions Regulation of Substances Fentanyl Research Funding Synthetic Opioids Health Risks of Cannabis Health Sciences Authority Drug Testing Cannabis Regulation Drug Alerts Drug-Related Deaths Drug Regulation Substance Use Prevention Strategies Monitoring Trends Cannabis Policy Charity Funding Addiction FDA Regulations Community Health

U.S. Teen Substance Use Stays Near Record Lows for Fifth Year, With Small Upticks in Heroin and Cocaine

Researchers attribute the sustained drop to pandemic-era shifts in teen routines.

Trump Awards First Mexican Border Defense Medals to 13 Service Members

Medetomidine Tied to Penn North Mass Overdose as Baltimore Updates Response Guidance

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research